NEXUS AG - DE0005220909 (Stock)
Hannover
Price | Diff.% | Date & Time | Bid volume | Bid | Ask | Ask volume |
---|---|---|---|---|---|---|
71,60 EUR
![]() |
0,2801% | 06.06.2025 08:16 | - | - | - | - |
Contact | |
---|---|
|
NEXUS AG Irmastraße 1 78166, Donaueschingen, DE |
Phone | +49-771-22960-0 |
Fax | + |
info@nexus-ag.de | |
Internet | http://www.nexus-ag.de |
IR Contact/PR Contact | Carmen Stangl/Carmen Stangl |
Symbol | DE0005220909EUR |
End of financial year | 31.12.2025 |
Issued capital | 1.245.308.647,80 EUR |
Shareholders | |
---|---|
Freefloat | 73,26% |
Luxempart SA | 10,06% |
Gerald Glasauer | 5,97% |
Allianz Global Investors GmbH | 2,55% |
Brown Capital Management LLC | 2,47% |
Crédit Mutuel Asset Management SA | 1,74% |
Financière de l'Échiquier SA | 1,07% |
Teslin Capital Management BV | 1,02% |
Herald Investment Management Ltd. | 0,69% |
Ingo Behrendt | 0,60% |
Lonvia Capital SASU | 0,58% |
Board | |
---|---|
Dr. Ingo Behrendt | Chairman of Managing Board |
Ralf Heilig | Member of Executive Committee |
Edgar Kuner | Member of Executive Committee |
Stefan A Dandl | Chairman of Supervisory Board |
Rolf Wöhrle | Member of Supervisory Board |
Florian Herger | Member of Supervisory Board |
Dr. Hans-Joachim König | Member of Supervisory Board |
Dr. Felicia M. Rosenthal | Member of Supervisory Board |
Dr. Dietmar Kubis | Member of Supervisory Board |
Juergen Rottler | Member of Supervisory Board |
Activity Description |
---|
NEXUS AG engages in the development and sale of software and hardware solutions. It operates through the following segments: NEXUS/DE, NEXUS/DIS, and NEXUS/ROE. The NEXUS/DE segment develops and distributes software solutions for the healthcare sector in the administrative and medical sectors in the German market. The NEXUS/DIS segment offers diagnostic software solutions, which are developed and distributed for both the German and international Market. The NEXUS/ROE segment is involved in the development and distribution of software solutions for the healthcare sector in the administrative and medical sectors in the international market. The company founded by Edgar Kuner in 1989 is headquartered in Donaueschingen, Germany. |